Spruce Point Capital Says Spruce Point Has A Short Position In Hims & Hers Health, Inc.; Identifies Serious Operational Risks Related To Several Third-Party Pharmacy Partners; Believe Shares Of Hims & Hers Health, Face Up To 25% To 40% Long-Term Downside Risk To $5.20-$6.50 Per Share
Portfolio Pulse from Happy Mohamed
Spruce Point Capital has taken a short position in Hims & Hers Health, Inc., citing serious operational risks related to several third-party pharmacy partners. Spruce Point believes that shares of Hims & Hers Health face a long-term downside of 25% to 40%.
July 13, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Spruce Point Capital has taken a short position in Hims & Hers Health, Inc. due to operational risks with third-party pharmacy partners. They predict a 25%-40% long-term downside for the stock.
The news directly mentions Hims & Hers Health, Inc. (HIMS) and the short position taken by Spruce Point Capital. The identified operational risks with third-party pharmacy partners and the predicted long-term downside of 25%-40% for the stock are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100